I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 21% ± 3% | |
| epithelial cell | 4 studies | 25% ± 5% | |
| GABAergic neuron | 3 studies | 33% ± 6% | |
| glutamatergic neuron | 3 studies | 39% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 5 studies | 21% ± 3% | |
| epithelial cell | 4 studies | 25% ± 5% | |
| GABAergic neuron | 3 studies | 33% ± 6% | |
| glutamatergic neuron | 3 studies | 39% ± 5% |
Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| brain | 4 studies | 27% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| thymus | 100% | 1587.10 | 653 / 653 | 99% | 17.65 | 601 / 605 |
| breast | 100% | 1307.67 | 459 / 459 | 99% | 15.15 | 1110 / 1118 |
| lung | 100% | 1446.13 | 578 / 578 | 99% | 10.10 | 1138 / 1155 |
| brain | 100% | 749.19 | 2636 / 2642 | 99% | 8.59 | 696 / 705 |
| prostate | 100% | 1090.58 | 245 / 245 | 98% | 10.84 | 494 / 502 |
| esophagus | 100% | 998.48 | 1445 / 1445 | 97% | 9.56 | 178 / 183 |
| bladder | 100% | 1102.62 | 21 / 21 | 97% | 9.62 | 490 / 504 |
| pancreas | 99% | 683.78 | 326 / 328 | 98% | 8.25 | 174 / 178 |
| kidney | 100% | 1001.22 | 89 / 89 | 97% | 13.50 | 875 / 901 |
| ovary | 100% | 1451.15 | 180 / 180 | 96% | 8.63 | 414 / 430 |
| stomach | 100% | 821.64 | 359 / 359 | 96% | 9.23 | 275 / 286 |
| uterus | 100% | 1259.14 | 170 / 170 | 96% | 10.26 | 440 / 459 |
| liver | 100% | 1057.70 | 226 / 226 | 95% | 8.15 | 384 / 406 |
| intestine | 100% | 945.74 | 965 / 966 | 94% | 8.88 | 494 / 527 |
| adrenal gland | 100% | 1154.16 | 258 / 258 | 92% | 8.80 | 211 / 230 |
| skin | 100% | 1449.94 | 1809 / 1809 | 90% | 11.32 | 426 / 472 |
| adipose | 100% | 1312.74 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 7.67 | 29 / 29 |
| spleen | 100% | 1303.74 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 4.98 | 1 / 1 |
| blood vessel | 100% | 823.82 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 99% | 649.08 | 854 / 861 | 0% | 0 | 0 / 0 |
| muscle | 98% | 513.72 | 788 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 93% | 7.46 | 42 / 45 |
| peripheral blood | 72% | 610.35 | 665 / 929 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 60% | 3.51 | 48 / 80 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0016266 | Biological process | O-glycan processing |
| GO_0016020 | Cellular component | membrane |
| GO_0140563 | Molecular function | UDP-D-xylose:beta-D-glucoside alpha-1,3-D-xylosyltransferase activity |
| GO_0035252 | Molecular function | UDP-xylosyltransferase activity |
| Gene name | GXYLT1 |
| Protein name | Glucoside xylosyltransferase 1 (EC 2.4.2.42) (Glycosyltransferase 8 domain-containing protein 3) |
| Synonyms | GLT8D3 |
| Description | FUNCTION: Glycosyltransferase which elongates the O-linked glucose attached to EGF-like repeats in the extracellular domain of Notch proteins by catalyzing the addition of xylose. . |
| Accessions | Q4G148 ENST00000280876.6 [Q4G148-2] ENST00000398675.8 [Q4G148-1] |
